ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,030 | -70.1% | 85 | -61.4% | 0.00% | -100.0% |
Q2 2023 | $10,149 | +31.8% | 220 | +14.6% | 0.00% | 0.0% |
Q1 2023 | $7,699 | -62.2% | 192 | -56.4% | 0.00% | -66.7% |
Q4 2022 | $20,385 | +307.7% | 440 | +286.0% | 0.00% | +200.0% |
Q3 2022 | $5,000 | +150.0% | 114 | +307.1% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 28 | +16.7% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 24 | +242.9% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 7 | -58.8% | 0.00% | – |
Q4 2019 | $1,000 | -75.0% | 17 | -80.5% | 0.00% | -100.0% |
Q3 2019 | $4,000 | 0.0% | 87 | +38.1% | 0.00% | 0.0% |
Q2 2019 | $4,000 | 0.0% | 63 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,000 | +100.0% | 63 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $2,000 | – | 63 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |